Alpa Laboratories Ltd

Alpa Laboratories Ltd

₹ 91.0 1.45%
21 May - close price
About

Incorporated in 1988, Alpa Laboratories Ltd manufactures and sells Drugs and Chemicals[1]

Key Points

Business Overview:[1]
ALL is a WHO-GMP and ISO 9001:2000 certified company. It manufactures a wide range of Pharmaceutical Finished Dosage Forms under its own brand and for other Indian and multinational companies. The product range includes a wide variety of ethical, generic, and over-the-counter (OTC) drugs in various Finished Dosage Forms for both human and veterinary use

  • Market Cap 191 Cr.
  • Current Price 91.0
  • High / Low 115 / 55.0
  • Stock P/E 10.7
  • Book Value 72.9
  • Dividend Yield 0.00 %
  • ROCE 8.99 %
  • ROE 7.26 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company is expected to give good quarter

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 8.57% over past five years.
  • Company has a low return on equity of 6.09% over last 3 years.
  • Earnings include an other income of Rs.10.2 Cr.
  • Company has high debtors of 184 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
33.16 24.99 31.52 26.26 29.33 25.50 22.42 13.54 27.31 29.16 25.43 32.39 27.31
30.23 23.76 28.98 22.73 25.61 26.86 21.00 19.28 24.68 19.90 26.58 29.07 24.85
Operating Profit 2.93 1.23 2.54 3.53 3.72 -1.36 1.42 -5.74 2.63 9.26 -1.15 3.32 2.46
OPM % 8.84% 4.92% 8.06% 13.44% 12.68% -5.33% 6.33% -42.39% 9.63% 31.76% -4.52% 10.25% 9.01%
1.18 0.64 4.26 2.70 2.20 3.72 1.61 6.38 2.69 -0.76 4.47 2.95 3.55
Interest 0.03 0.02 0.04 0.06 0.08 0.07 0.03 0.08 0.07 0.04 0.02 0.04 0.03
Depreciation 0.31 0.35 0.31 0.42 0.43 0.50 0.34 0.36 0.10 0.53 0.28 0.49 0.66
Profit before tax 3.77 1.50 6.45 5.75 5.41 1.79 2.66 0.20 5.15 7.93 3.02 5.74 5.32
Tax % -0.00% 235.33% -0.00% -0.00% -0.00% 304.47% -0.00% -0.00% -0.00% 41.74% -0.00% -0.00% 14.85%
3.77 -2.03 6.45 5.75 5.41 -3.66 2.66 0.20 5.14 4.62 3.03 5.74 4.53
EPS in Rs 1.79 -0.96 3.07 2.73 2.57 -1.74 1.26 0.10 2.44 2.20 1.44 2.73 2.15
Raw PDF
Upcoming result date: 28 May 2024

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
55 56 56 57 53 63 62 77 85 97 112 93 114
53 53 51 54 47 56 57 76 79 90 101 85 100
Operating Profit 3 3 6 3 7 7 4 1 6 8 11 8 14
OPM % 5% 5% 10% 6% 13% 11% 7% 2% 7% 8% 10% 9% 12%
1 0 1 2 6 4 5 5 0 4 11 9 10
Interest 1 2 2 2 1 2 1 1 0 0 0 0 0
Depreciation 1 5 9 6 1 1 1 1 1 1 2 1 2
Profit before tax 1 -3 -5 -3 11 9 7 5 5 11 20 16 22
Tax % 37% -36% -4% 48% 27% 34% 27% 36% 20% 33% 28% 21%
1 -4 -5 -1 8 6 5 3 4 7 14 13 18
EPS in Rs 0.25 -2.08 -2.45 -0.67 3.68 2.85 2.27 1.40 1.94 3.45 6.72 6.00 8.52
Dividend Payout % -0% -0% -0% -0% -0% -0% -0% -0% -0% -0% -0% -0%
Compounded Sales Growth
10 Years: 5%
5 Years: 9%
3 Years: 3%
TTM: 29%
Compounded Profit Growth
10 Years: 16%
5 Years: 15%
3 Years: 23%
TTM: 312%
Stock Price CAGR
10 Years: 26%
5 Years: 30%
3 Years: 17%
1 Year: 57%
Return on Equity
10 Years: 4%
5 Years: 5%
3 Years: 6%
Last Year: 7%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 21 21 21 21 21 21 21 21 21 21 21 21 21
Reserves 77 72 67 66 73 77 82 85 89 96 111 123 132
12 17 23 29 24 11 6 2 0 0 6 3 2
20 14 15 13 27 20 17 21 21 33 28 30 39
Total Liabilities 130 125 127 128 145 129 127 129 131 150 165 178 194
9 80 73 5 5 5 6 6 6 7 9 7 7
CWIP 59 -0 -0 0 -0 -0 -0 0 1 2 -0 -0 -0
Investments -0 -0 -0 10 22 23 41 59 68 62 86 90 117
62 45 54 113 118 100 79 64 56 80 70 81 70
Total Assets 130 125 127 128 145 129 127 129 131 150 165 178 194

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
-1 3 8 -2 -25 -8 -7 -1 18 -1 2 9
-1 -4 -2 37 -7 1 -16 -15 -11 6 -16 2
1 2 4 7 -6 -2 4 -5 -1 -0 5 -3
Net Cash Flow -1 0 10 42 -37 -9 -19 -20 5 4 -8 7

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 142 127 130 156 234 169 151 141 105 133 124 184
Inventory Days 142 132 148 76 196 131 140 105 90 102 81 84
Days Payable 142 85 121 91 244 140 130 99 98 152 78 100
Cash Conversion Cycle 142 174 157 141 187 160 161 148 97 83 127 168
Working Capital Days 265 187 169 178 390 256 234 194 121 137 136 155
ROCE % 2% -1% -3% 0% 10% 11% 7% 4% 7% 7% 9% 9%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
56.66% 56.66% 56.66% 57.29% 57.29% 57.29% 57.29% 57.29% 57.29% 57.29% 57.29% 57.29%
0.00% 0.00% 0.09% 0.56% 0.21% 0.14% 0.00% 0.00% 0.00% 0.11% 0.95% 0.50%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.01% 0.00% 0.00% 0.00%
0.00% 0.00% 0.05% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
43.34% 43.34% 43.20% 42.15% 42.50% 42.56% 42.70% 42.70% 42.70% 42.59% 41.74% 42.21%
No. of Shareholders 15,54715,59516,11418,77518,79618,84019,09419,13718,74518,56518,68218,690

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents